Market Currents
More on Cepheid's (CPHD) Q4: Cites strong demand for its GeneXpert systems, despite tight...
-
Thursday, January 26, 2012, 4:33 PM ETMore on Cepheid's (CPHD) Q4: Cites strong demand for its GeneXpert systems, despite tight capital in U.S. and Europe. Sets 2012 revenue guidance at $333M-$347M. Sees EPS falling in a range of $0.55 to $0.60. Shares +19.4% AH. (PR)
Other date
Latest Earnings Articles
